Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Revati J. Tatake is active.

Publication


Featured researches published by Revati J. Tatake.


Biochemical and Biophysical Research Communications | 2008

Identification of pharmacological inhibitors of the MEK5/ERK5 pathway.

Revati J. Tatake; Margaret M. O’Neill; Charles A. Kennedy; Anita L. Wayne; Scott Jakes; Di Wu; Stanley Z. Kugler; Mohammed A. Kashem; Paul Kaplita; Roger J. Snow

We have identified two novel MEK5 inhibitors, BIX02188 and BIX02189, which inhibited catalytic function of purified, MEK5 enzyme. The MEK5 inhibitors blocked phosphorylation of ERK5, without affecting phosphorylation of ERK1/2 in sorbitol-stimulated HeLa cells. The compounds also inhibited transcriptional activation of MEF2C, a downstream substrate of the MEK5/ERK5 signaling cascade, in a cellular trans-reporter assay system. These inhibitors offer novel pharmacological tools to better characterize the role of the MEK5/ERK5 pathway in various biological systems.


Nature Medicine | 2006

A crucial role of mitochondrial Hsp40 in preventing dilated cardiomyopathy

Masaaki Hayashi; Kyoko Imanaka-Yoshida; Toshimichi Yoshida; Malcolm R. Wood; Colleen Fearns; Revati J. Tatake; Jiing-Dwan Lee

Many heat-shock proteins (Hsp) are members of evolutionarily conserved families of chaperone proteins that inhibit the aggregation of unfolded polypeptides and refold denatured proteins, thereby remedying phenotypic effects that may result from protein aggregation or protein instability. Here we report that the mitochondrial chaperone Hsp40, also known as Dnaja3 or Tid1, is differentially expressed during cardiac development and pathological hypertrophy. Mice deficient in Dnaja3 developed dilated cardiomyopathy (DCM) and died before 10 weeks of age. Progressive respiratory chain deficiency and decreased copy number of mitochondrial DNA were evident in cardiomyocytes lacking Dnaja3. Profiling of Dnaja3-interacting proteins identified the α-subunit of DNA polymerase γ (Polga) as a client protein. These findings suggest that Dnaja3 is crucial for mitochondrial biogenesis, at least in part, through its chaperone activity on Polga and provide genetic evidence of the necessity for mitochondrial Hsp40 in preventing DCM.


Microcirculation | 2011

MEK5 is Activated by Shear Stress, Activates ERK5 and Induces KLF4 to Modulate TNF Responses in Human Dermal Microvascular Endothelial Cells

Paul R. Clark; Todd J. Jensen; Martin S. Kluger; Maurice M. Morelock; Adedayo Hanidu; Zhenhao Qi; Revati J. Tatake; Jordan S. Pober

Please cite this paper as: Clark, Jensen, Kluger, Morelock, Hanidu, Qi, Tatake, Pober (2011). MEK5 is Activated by Shear Stress, Activates ERK5 and Induces KLF4 to Modulate TNF Responses in Human Dermal Microvascular Endothelial Cells. Microcirculation18(2), 102–117.


Biochemical and Biophysical Research Communications | 2008

Fluid shear stress inhibits TNF-mediated JNK activation via MEK5-BMK1 in endothelial cells

Lingli Li; Revati J. Tatake; Kanchana Natarajan; Yoji Taba; Gwen Garin; Caspar Tai; Ed Leung; James Surapisitchat; Masanori Yoshizumi; Chen Yan; Jun Ichi Abe; Bradford C. Berk

Steady laminar blood flow protects vessels from atherosclerosis. We showed that flow decreased tumor necrosis factor-alpha (TNF)-mediated VCAM1 expression in endothelial cells (EC) by inhibiting JNK. Here, we determined the relative roles of MEK1, MEK5 and their downstream kinases ERK1/2 and BMK1 (ERK5) in flow-mediated inhibition of JNK activation. Steady laminar flow (shear stress=12dyn/cm(2)) increased BMK1 and ERK1/2 activity in EC. Pre-exposing EC for 10min to flow inhibited TNF activation of JNK by 58%. A key role for BMK1, but not ERK1/2 was shown. (1) Incubation of EC with PD184352, at concentrations that blocked ERK1/2, but not BMK1, had no effect on flow inhibition of TNF-mediated JNK activation. (2) BIX02188, a MEK5-selective inhibitor, completely reversed the inhibitory effects of flow. These findings indicate that flow inhibits TNF-mediated signaling events in EC by a mechanism dependent on activation of MEK5-BMK1, but not MEK1-ERK1/2. These results support a key role for the MEK5-BMK1 signaling pathway in the atheroprotective effects of blood flow.


Apoptosis | 2001

Disparate cleavage of poly-(ADP-ribose)-polymerase (PARP) and a synthetic tetrapeptide, DEVD, by apoptotic cells.

K. Yu; Charles A. Kennedy; Margaret M. O'neill; Randall W. Barton; Revati J. Tatake

In the present investigations, we have shown differential cleavage of cellular PARP and a caspase 3-selective synthetic tetrapeptide substrate, Z-DEVD-AFC or Ac-DEVD-AMC using a T lymphoblastoid cell line Jurkat, and its variant clone E6.1(J-E6). Anti-Fas antibody-mediated apoptosis resulted in DNA fragmentation and PARP cleavage in both Jurkat and J-E6 cells. However, unlike Jurkat, J-E6 cells did not cleave a synthetic tetrapeptide substrate efficiently. The failure to cleave the DEVD tetrapeptide by apoptotic J-E6 cells was not due to insufficient expression or processing of caspase 3 in J-E6 cells. Interestingly, when the J-E6 cells were transiently transfected with a cDNA encoding caspase 3, efficient cleavage of Z-DEVD-AFC was achieved. The observations that apoptotic J-E6 cells barely cleaved a synthetic DEVD tetrapeptide, but efficiently cleaved endogenous PARP, potentially at the most preferred DEVD site, suggest that active caspases may have disparate characteristics to recognize substrates presented in different context.


Archive | 2007

Modified nucleotide sequence encoding glucagon-like peptide-1 (glp-1), nucleic acid construct comprising same for production of glucagon-like peptide-1 (glp-1), human cells comprising said construct and insulin-producing constructs, and methods of use thereof

Revati J. Tatake; Margaret M. O'neill; Kelli-Ann Monaco


Archive | 1999

Self-regulated apoptosis of inflammatory cells by gene therapy

Revati J. Tatake; Steven D. Marlin; Randall W. Barton


Life Sciences | 2007

Glucose-regulated insulin production from genetically engineered human non-beta cells

Revati J. Tatake; Margaret M. O'neill; Charles A. Kennedy; Virginia D. Reale; Jacob D. Runyan; Kelli Ann D Monaco; Kyung Yu; William R. A. Osborne; Randall W. Barton; Richard D. Schneiderman


Archive | 2002

Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines

Revati J. Tatake; Richard D. Schneiderman; Randall Wilber Barton


Archive | 2008

MODIFIED NUCLEOTIDE SEQUENCE ENCODING GLUCAGON-LIKE PEPTIDE-1 (GLP-1)

Revati J. Tatake; Margaret M. O'neill; Kelli-Ann Monaco

Collaboration


Dive into the Revati J. Tatake's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Di Wu

Boehringer Ingelheim

View shared research outputs
Researchain Logo
Decentralizing Knowledge